Platinum + Gemcitabine

DRUG2 trials

Sponsors

Eli Lilly and Company, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Conditions

Bladder (Urothelial, Transitional Cell) Cancer Metastatic or UnresectableNon-Small-Cell Lung CarcinomaUpper Tract Urothelial Cancer

Phase 2

Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

CompletedNCT00112346

Eli Lilly and CompanyNon-Small-Cell Lung Carcinoma

Start: 2005-01-31End: 2006-12-31Target: 120Updated: 2015-10-28

Phase 4

DDR Genes Alteration and Response to Platinum-based Chemotherapy in Advanced Urothelial Cancer.

RecruitingNCT06820255

Fondazione Policlinico Universitario Agostino Gemelli IRCCSBladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable, Upper Tract Urothelial Cancer

Start: 2025-01-07End: 2027-01-07Target: 135Updated: 2025-02-11